Inventor · disambiguated record
Vincenzo Cannata
Also filed as: CANNATA VINCENZO · CANNATA VINZENZO
42 granted patents·35 pending applications·636 citations·filing 1981–2022
98Inventor score
Files withALFA WASSERMANN SPA18VISCOMI GIUSEPPE CLAUDIO10ALFA CHEM ITAL9ALFASIGMA SPA8ZACH SYSTEM SPA8
Top patents by PatentIndex Score
77 records- 0197US8158781B2Polymorphic forms α, β and γ of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted Apr 17, 2012·27 cites·8 claims
- 0297US7902206B2Polymorphic forms α, β and γ of rifaximinALFA WASSERMANN SPA·Filed 2008·Granted Mar 8, 2011·28 cites·57 claims
- 0397US7045620B2Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparationsALFA WASSERMANN SPA·Filed 2003·Granted May 16, 2006·139 cites·20 claims
- 0496US8835452B2Polymorphic forms α, β and γ of rifaximinALFA WASSERMANN SPA·Filed 2012·Granted Sep 16, 2014·15 cites·21 claims
- 0596US7906542B2Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximinALFA WASSERMANN SPA·Filed 2008·Granted Mar 15, 2011·40 cites·25 claims
- 0695US8158644B2Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted Apr 17, 2012·26 cites·20 claims
- 0795US7923553B2Processes for the production of polymorphic forms of rifaximinALFA WASSERMANN SPA·Filed 2008·Granted Apr 12, 2011·18 cites·46 claims
- 0893US8853231B2Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximinALFA WASSERMANN SPA·Filed 2012·Granted Oct 7, 2014·15 cites·18 claims
- 0992US8173801B2Processes for the production of polymorphic forms of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted May 8, 2012·14 cites·19 claims
- 1092US4557866AProcess for the synthesis of pyrido-imidazo rifamycinsALFA FARMACEUTICI SPA·Filed 1985·Granted Dec 10, 1985·113 cites·4 claims
- 1184US4962223AProcess for the synthesis of the levodopaMINI RICERCA SCIENT TECNOLOG·Filed 1989·Granted Oct 9, 1990·23 cites·9 claims
- 1283US7683052B2Crystalline polymorph of bazedoxifene acetateWYETH CORP·Filed 2005·Granted Mar 23, 2010·9 cites·41 claims
- 1382US5760220AProcess for preparation of biphenyl derivativesAMERICAN HOME PROD·Filed 1996·Granted Jun 2, 1998·31 cites·46 claims
- 1480US2022127283A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2022·Application pending·0 cites
- 1579US8318763B2Rifamycin derivativesVISCOMI GIUSEPPE CLAUDIO·Filed 2009·Granted Nov 27, 2012·5 cites·19 claims
- 1679US5550287AProcess for the preparation and purification of iodinated contrast agentsZAMBON SPA·Filed 1995·Granted Aug 27, 1996·24 cites·8 claims
- 1778US5811586AProcess for manufacturing 1-(3-trifluoromethyl)-phenyl-propan-2-one intermediate in the synthesis of the fenfluramineALFA CHEM ITAL·Filed 1997·Granted Sep 22, 1998·24 cites·6 claims
- 1876US5808156AProcess for the production of the isomers (R) and (S)-α-methyl-3(trifluoromethyl)benzeneethanamineALFA CHEM ITAL·Filed 1997·Granted Sep 15, 1998·21 cites·4 claims
- 1975US8183367B2Methods of preparing polymorphic form A of bazedoxifene acetateANDREELLA PAOLO·Filed 2009·Granted May 22, 2012·3 cites·3 claims
- 2073US7759517B2Process for the preparation of gabapentinZACH SYSTEM SPA·Filed 2005·Granted Jul 20, 2010·2 cites·19 claims
- 2173US2020339599A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2020·Application pending·0 cites
- 2273US2019263829A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2019·Application pending·0 cites
- 2373US2020339600A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2020·Application pending·0 cites
- 2472US2015175627A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2014·Application pending·0 cites
- 2571US2019263830A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2019·Application pending·0 cites
- 2670US2019135831A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2018·Application pending·0 cites
- 2769US2007249718A1Stable gabapentin compositionsZACH SYSTEM SPA·Filed 2007·Application pending·0 cites
- 2868US2019135830A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2018·Application pending·0 cites
- 2967US8765778B2Rifamycin derivativesALFA WASSERMANN SPA·Filed 2012·Granted Jul 1, 2014·1 cites·29 claims
- 3067US4399284AProcess for the optical resolution of mixtures of D- and L-2-(6-methoxy-2-naphthyl)-propionic acidsALFA FARMACEUTICI SPA·Filed 1981·Granted Aug 16, 1983·6 cites·12 claims
- 3167US2018065987A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2017·Application pending·0 cites
- 3267US2008262024A1Rifaximin compositions and method of useVISCOMI GIUSEPPE CLAUDIO·Filed 2008·Application pending·0 cites
- 3367US2015182508A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2014·Application pending·0 cites
- 3466US4724102AOptical resolution of racemic mixtures of alpha-naphthylpropionic acids and derivatives of said acidsALFA CHEM ITAL·Filed 1986·Granted Feb 9, 1988·9 cites·21 claims
- 3566US4423244AProcess for the preparation of the d-2-(6-methoxy-2-naphthyl)-propionic acidALFA CHEM ITAL·Filed 1982·Granted Dec 27, 1983·8 cites·14 claims
- 3666US2012203000A1Polymorphic forms alpha, beta and gamma of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Application pending·0 cites
- 3766US2017210758A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2016·Application pending·0 cites
- 3865US2018065988A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2017·Application pending·0 cites
- 3963US2017210757A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2016·Application pending·0 cites
- 4062US2012202989A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Application pending·0 cites
- 4162US2008300307A1Stable gabapentin compositionsZACH SYSTEM SPA·Filed 2008·Application pending·0 cites
- 4259US7449583B2Process for the preparation of 4-(8-chloro-5 6-dihydro-11h-benzo-(5 6)-cyclohepta-(1 2b)-pyridin-11-ylidene-1-piperidiniecarboxylic acid ethyl ester (loratadine)ZACH SYSTEM SPA·Filed 2002·Granted Nov 11, 2008·1 cites·3 claims
- 4359US5750793AProcess for the synthesis of nabumetoneALFA CHEM ITAL·Filed 1997·Granted May 12, 1998·7 cites·7 claims
- 4458US2005272754A1Polymorphic forms of rifaximin, processes for their production and uses thereofALFA WASSERMANN SPA·Filed 2005·Application pending·0 cites
- 4557US4661628AProcess for the optical resolution of racemic mixtures of α-naphthyl-propionic acidsALFA CHEM ITAL·Filed 1984·Granted Apr 28, 1987·5 cites·27 claims
- 4657US2012258166A1Rifaximin compositions and method of useVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Application pending·0 cites
- 4757US2009005567A1Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo (5,6)-cyclohepta-(1,2b) -pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester (loratadine)ZACH SYSTEM SPA·Filed 2008·Application pending·0 cites
- 4857US2022119410A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2021·Application pending·0 cites
- 4956US6355836B1Process for the preparation of cis 5-fluoro-2-methyl-1[p-(methylthio)benzyliden]-inden-3-acetic acidZAMBON SPA·Filed 2000·Granted Mar 12, 2002·1 cites·4 claims
- 5056US2006122272A1Stable gabapentin compositionsZAMBON SPA·Filed 2006·Application pending·0 cites
Showing the top 50 of 77 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Vincenzo Cannata files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →